J
Jeff M. Michalski
Researcher at Washington University in St. Louis
Publications - 393
Citations - 24291
Jeff M. Michalski is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Prostate cancer & Radiation therapy. The author has an hindex of 73, co-authored 330 publications receiving 20977 citations. Previous affiliations of Jeff M. Michalski include American Urological Association & American Society for Radiation Oncology.
Papers
More filters
Journal ArticleDOI
Redesigning radiotherapy quality assurance: opportunities to develop an efficient, evidence-based system to support clinical trials--report of the National Cancer Institute Work Group on Radiotherapy Quality Assurance.
Justin E. Bekelman,J Deye,Bhadrasain Vikram,Søren M. Bentzen,Deborah Watkins Bruner,Walter J. Curran,James J. Dignam,Jason A. Efstathiou,T.J. FitzGerald,Coen W. Hurkmans,Geoffrey S. Ibbott,J. Jack Lee,Thomas E. Merchant,Jeff M. Michalski,Jatinder R. Palta,Richard Simon,Randal K. Ten Haken,Robert Timmerman,Sean Tunis,C. Norman Coleman,James A. Purdy +20 more
TL;DR: A 2-day workshop to examine challenges and opportunities for optimizing radiotherapy quality assurance (QA) in clinical trial design and explore the feasibility of consolidating clinical trial QA in the United States.
Journal ArticleDOI
Extensive Molecular and Clinical Heterogeneity in Patients With Histologically Diagnosed CNS-PNET Treated as a Single Entity: A Report From the Children’s Oncology Group Randomized ACNS0332 Trial
Eugene Hwang,Marcel Kool,Peter C. Burger,David Capper,David Capper,Lukas Chavez,Sebastian Brabetz,Chris Williams-Hughes,Catherine A. Billups,Linda Heier,Alok Jaju,Jeff M. Michalski,Yimei Li,Sarah Leary,Sarah Leary,Tianni Zhou,Andreas von Deimling,David T.W. Jones,Maryam Fouladi,Ian F. Pollack,Amar Gajjar,Roger J. Packer,Stefan M. Pfister,Stefan M. Pfister,James M. Olson,James M. Olson +25 more
TL;DR: For patients with CNS-PNET/PBL, prognosis is considerably better than previously assumed when molecularly confirmed HGGs are removed and indicates that molecular profiling should become a standard component of initial diagnosis.
Journal ArticleDOI
Interstitial implant alone or in combination with external beam radiation therapy for intermediate-risk prostate cancer: a survey of practice patterns in the United States.
Steven J. Frank,Peter D. Grimm,John Sylvester,Gregory S. Merrick,Brian J. Davis,Anthony L. Zietman,Brian J. Moran,David C. Beyer,Mack Roach,Daniel H. Clarke,Richard G. Stock,W. Robert Lee,Jeff M. Michalski,Kent E. Wallner,Mark D. Hurwitz,Louis Potters,Deborah A. Kuban,Bradley R. Prestidge,Robyn Vera,Shannon Hathaway,John C. Blasko +20 more
TL;DR: This Patterns of Care (POC) study reveals that certain subsets of intermediate-risk localized prostate cancer patients are considered appropriate candidates for an interstitial implant alone.
Journal ArticleDOI
A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902
Seth A. Rosenthal,Daniel Hunt,A. Oliver Sartor,Kenneth J. Pienta,Leonard G. Gomella,David J. Grignon,Raghu Rajan,Kevin J. Kerlin,Christopher U. Jones,Michael C. Dobelbower,William U. Shipley,Kenneth L. Zeitzer,Daniel A. Hamstra,Viroon Donavanik,Marvin Rotman,Alan C. Hartford,Jeff M. Michalski,Michael I. Seider,Harold Kim,Deborah A. Kuban,Jennifer Moughan,Howard M. Sandler +21 more
TL;DR: The trial results provide valuable data regarding the natural history of high-risk PCa treated with LT AS + RT and have implications for the feasibility of clinical trial accrual and tolerability using CT for PCa.
Journal ArticleDOI
Hydrogel spacer distribution within the perirectal space in patients undergoing radiotherapy for prostate cancer: Impact of spacer symmetry on rectal dose reduction and the clinical consequences of hydrogel infiltration into the rectal wall
TL;DR: Significant reduction of rectal dose can still be achieved even in the setting of asymmetric hydrogel spacer placement, and RWI does not correlate with patient complications.